14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Jespsen JS, Sorensen MD <strong>and</strong> Wengel J. Locked Nucleic Acid: a potent nucleic acid<br />

analogue in therapeutics <strong>and</strong> biotechnology. Oligonucleotides. 2004 14(2): 130-146.<br />

Vollmer J, Jepsen JS, Uhlmann E, Schetter C, Jurk M, Wader T, Wullner M <strong>and</strong> Krieg AM.<br />

Modulation of antisense or CpG oligodeoxynucleotide-mediated immune stimulation by<br />

locked nucleic acid (LNA). Oligonucleotides. 2004 14(1):23-32.<br />

Jepsen JS <strong>and</strong> Wengel J. LNA-Antisense rivals siRNA for gene silencing.<br />

Current Opinion in Drug Discovery <strong>and</strong> Development. 2004 7(2):188-194.<br />

Jepsen JS. Locked nucleic acid (lna) as a therapeutic tool to knock down gene expression.<br />

Encyclopedia of medical genomics <strong>and</strong> proteomics. Accepted.<br />

Jepsen JS <strong>and</strong> Kauppinen S. Locked nucleic acid (lna) as a tool in biotechnology research<br />

<strong>and</strong> diagnostics. Encyclopedia of medical genomics <strong>and</strong> proteomics. Accepted.<br />

Stein CA, Dias N, Benimetskaya L, Jepsen JS, Lai J <strong>and</strong> Raffo A. LY900003 (Isis 3521) <strong>and</strong><br />

G3139 (Genasense; Oblimersen)- Phosphorothioate Antisense Oligonucleotides With<br />

Pleiotropic Mechanisms of Action. Nucleic Acid Therapeutics in Cancer (2004), pp. 177-198.<br />

Edited by Gerwirtz, A., Humana Press (ISBN: 1-58829-258-4).<br />

Hrdlicka, P.J., Jepsen, J.S., Nielsen, C <strong>and</strong> Wengel, J.: Synthesis <strong>and</strong> biological evaluation of<br />

conformationally restricted <strong>and</strong> nucleobase-modified analogs of the anticancer compound 3'-<br />

C-ethynylcytidine (ECyd). Nucleosides Nucleotides Nucleic Acids. 2005 24(5-7): 397-400.<br />

Hrdlicka PJ, Jepsen JS, Nielsen C <strong>and</strong> Wengel J. Synthesis <strong>and</strong> biological evaluation of<br />

nucleobase-modified analogs of the anticancer compounds 3’-C-ethynyluridine (EUrd) <strong>and</strong><br />

3’-C-ethynylcytidine (ECyd).<br />

Bioorganic & Medicinal Chemistry. 2005 13(4): 1249-1260<br />

Hrdlicka PJ, Andersen NK, Jepsen JS, Hansen FG, Haselmann KF, Nielsen C <strong>and</strong> Wengel J.<br />

Synthesis <strong>and</strong> biological evaluation of branched <strong>and</strong> conformationally restricted analogs of<br />

the anticancer compounds 3’-C-ethynyluridine (EUrd) <strong>and</strong> 3’-C-ethynylcytidine (ECyd).<br />

Bioorganic & Medicinal Chemistry. 2005 13(7): 2597-2621<br />

Kragelund BB, Poulsen K, Andersen KV, Baldursson T, Kroll JB, Neergard TB, Jepsen J,<br />

Roepstorff P, Kristiansen K, Poulsen FM <strong>and</strong> Knudsen J. Conserved residues <strong>and</strong> their role in<br />

the structure, function, <strong>and</strong> stability of acyl-coenzyme A binding protein. Biochemistry. 1999<br />

Feb 23; 38(8):2386-94.<br />

Jepsen JS Locked nucleic acid (LNA) as cancer-therapeutic agent. Dan Med Bull 2004<br />

51:139.<br />

- 55 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!